- Dividend Brief
- Posts
- The Dividend Aristocrat Now Yielding Over 5% After a Brutal Reset
The Dividend Aristocrat Now Yielding Over 5% After a Brutal Reset
The market has treated one of the sturdiest consumer staples names like a broken business. Coverage is intact, the annual dividend hike is on the calendar for early August, and the trailing yield just crossed a level it hasn't touched in over a decade.
Consumer staples were supposed to be the safe corner of the market. That thesis got torched over the past year, and one of the sturdiest names in the group is now paying you more than 5% to wait, right into what should be its next annual dividend hike. This is the kind of setup you rarely get on a Dividend Aristocrat with a wide-moat rating.
Standout Picks Now (Sponsored)
Every market cycle produces a handful of companies that dramatically outperform the rest.
Our latest screening has identified the 5 Stocks Set to Double — companies showing rare early-stage momentum traits.
These picks carry the same indicators that historically precede strong rallies.
Past reports highlighted stocks that surged +175%, +498%, and +673%.
Get the Free 5 Stocks Set to Double Report.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Meet the Aristocrat on Sale
The stock is Clorox (NYSE: CLX). Yes, the bleach company, but that vastly understates the business. Clorox owns a portfolio of category-leading brands most people touch every week: Kingsford charcoal, Glad bags, Hidden Valley Ranch, Brita filters, Burt's Bees, Pine-Sol, and the namesake cleaning lineup.
It's an approximately $11.79 billion market cap company that has raised its dividend for more than 20 consecutive years, and right now it's trading closer to its 52-week low ($84.70) than its high ($132.03). The reset in the shares has done the work for you on entry.
The Annual Hike Announcement Is the Real Catalyst
Here's what most commentary misses. Clorox's fiscal year ends in June, and the company has a decades-long pattern of announcing its annual dividend increase alongside fiscal Q4 results in early August. That's the catalyst that matters, and it lines up perfectly with the current selloff.
Every year, this announcement resets the yield conversation. Aristocrat status requires a hike, and management has signaled repeatedly that returning cash to shareholders is a non-negotiable.
With the stock down and the current annual payout already yielding around 5.20% at current prices, even a modest low-single-digit bump would push the forward number closer to 5.3% or higher. That's a re-rating trigger for yield-focused capital that has been sitting on the sidelines waiting for a durable 5%-plus yield with a real dividend track record behind it.
The setup is compressed because the market is treating Clorox like a broken staples name. It isn't. It's a temporarily cheap one with a scheduled catalyst inside 30 to 45 days.
Income Strategy (Sponsored)
His official paycheck? $400,000 a year.
But the real story is somewhere else: As much as $250,000 per month… from a single source.
It’s not real estate. It’s not the stock market.
So what’s actually producing this level of cash flow — and why are more investors turning to it today?
The IGNITE Program Is Doing the Heavy Lifting
Clorox has been running its multi-year IGNITE transformation, and this is where the fundamentals get interesting. Management has been cutting stranded costs, simplifying the supply chain, and rebuilding gross margin after the pandemic-era commodity shock knocked the P&L sideways.
The math you care about: gross margin has been recovering steadily quarter after quarter as pricing sticks and input costs normalize.
Morningstar currently rates CLX as trading at a premium to its fair value estimate, meaning the market-implied upside thesis rests more on margin recovery and the dividend catalyst than on a valuation gap to a Morningstar target.
You don't need a deep discount to make the trade work. The yield alone, plus a credible path to gross margin normalization, gets you a respectable total return from here.
Action: Start accumulating between $92 and $100 ahead of the August fiscal Q4 print and the annual dividend increase announcement. Add on any dip toward the 52-week low near $85. |
A-Rated AI Opportunity (Sponsored)
Louis Navellier says his $9 million Stock Grader system is flashing its highest rating on one AI stock for 2026.
This company recently reported record annual revenue of $113.5 billion, earned an A-rating in his system, and is tied to a major AI expansion linked to Elon Musk’s “Project Apex.”
Navellier says this is the same system that helped him spot Nvidia long before its historic run.
Now, he is revealing the name, ticker, and full analysis of his #1 AI stock pick for 2026, completely free.
Category Leadership That Doesn't Show Up in the Multiple
Clorox owns the #1 or #2 market share position in most of its categories. That matters because shelf space at Walmart, Target, Costco, and Kroger is essentially guaranteed. Retailers don't drop category leaders, they negotiate on price and promotion.
Three structural tailwinds you're getting for free here:
- The bleach and cleaning categories saw a private label surge during the inflation spike, and that share loss is stabilizing as consumer wallets recover.
- International, which has been a drag, has been streamlined and is now a smaller but higher-margin contributor.
- Burt's Bees and Hidden Valley are still growing above the company average, giving the mix a slow lift.
That last point matters more than it sounds. As the higher-margin franchises grow faster than the legacy bleach business, blended gross margin drifts higher without needing any pricing heroics.
The Super Bowl Indicator claims to predict market direction based on which conference wins. What does an NFC win supposedly signal? |
What the Fundamentals Actually Say
Strip out the noise from the selloff and the underlying business is a steady improver. Free cash flow generation remains strong enough to cover the dividend with room to spare, and the balance sheet, while carrying debt from prior years, has been getting worked down.
The trailing 12-month payout ratio sits at a level that's elevated but not stretched for a company with Clorox's cash generation profile.
Consensus estimates have been drifting up on gross margin recovery, and even a slight upside surprise on fiscal Q4 could shift the narrative fast. The stock is trading like the business is broken. It isn't.
The Yield You Rarely Get on This Ticker
Clorox's dividend history is what makes this setup interesting. Over 20 consecutive years of increases. A trailing yield of around 5.20% at current prices, which is materially above the 5-year average yield on the stock (historically closer to the low-to-mid 3% range).
When a blue-chip staples name yields 5% or more, one of two things is happening: the dividend is at risk, or the market is offering you a discount that doesn't last. In Clorox's case, coverage is intact and the annual hike is on the calendar. That combination almost never persists for long.
Action: If you're looking for a defensive income anchor in your portfolio, this is exactly the profile you want. |
Where This Trade Can Go Wrong
I'd be doing you a disservice not to lay out the risks. Private label share gains at Walmart and the club channels remain the single biggest structural threat, especially in bleach and trash bags. If Costco's Kirkland brand keeps eating into Glad, that pressures the mix.
Second, input cost inflation could return. Resin, energy, and transportation are all sensitive to oil prices. WTI crude is currently trading around $67.53, well below levels that would meaningfully pressure input costs, but a sustained move materially higher from here would squeeze the gross margin recovery and bear watching.
Third, if fiscal Q4 disappoints on volume rather than price, the narrative that consumers are trading down gets validated, and the stock could see another leg lower before the dividend catalyst provides support. Position size accordingly and leave room to add lower if needed.
Why This One Belongs on Your Radar Now
The setup is simple. You have a wide-moat Dividend Aristocrat trading near its 52-week low, yielding over 5% on trailing dividends, with a scheduled catalyst (fiscal Q4 earnings and annual dividend hike) inside the next six weeks.
IGNITE cost savings are showing up in margins, category leadership is intact, and the balance sheet is being repaired.
You don't get 5%-plus yields on Aristocrats often. When you do, it usually pays to buy them. Clorox isn't a growth story, and it isn't going to double overnight.
But if you're building an income sleeve that needs to hold up when the market gets ugly, this is the kind of name you want to own before the hike announcement, not after.
Setup Scorecard
Entry Zone: $92 to $100 (add on dips toward $85)
Target: $125 to $135 over 12 to 18 months as margin recovery plays out
Stop Loss: Reassess below $82 (below 52-week low = thesis break)
Catalyst Timeline: Fiscal Q4 earnings and annual dividend hike announcement in early August 2026
Confidence Level: Medium-High. The Aristocrat status, scheduled hike, and 5%-plus yield give you multiple ways to win, but private label pressure and input costs keep this from being a slam-dunk.
That’s all for today’s edition of the Dividend Brief.
Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!
—Noah Zelvis
DividendBrief.com